CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. Revance Therapeutics, Inc. Transaction History

CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. portfolio value:

$18,000
portfolio value

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 684 shares 18K $27 684